SYSTEMATIC REVIEW/META-ANALYSIS
The association between frailty and headache in middle-aged and older individuals: a data analysis based on the GBD2021, the CHARLS and Mendelian randomization
More details
Hide details
1
School Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China
These authors had equal contribution to this work
Submission date: 2025-11-09
Final revision date: 2025-12-29
Acceptance date: 2026-01-13
Online publication date: 2026-04-12
Corresponding author
Yu Qiao
School Basic
Medical Sciences
Heilongjiang University
of Chinese Medicine
Harbin, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Headache is a common neurological disease with a significant impact on individuals and a high social economic burden.
Material and methods:
We explored the association between frailty (assessed by FI) and incidence of new headaches among older individuals using the Global Burden of Disease database and the China Health and Retirement Longitudinal Study (CHARLS).
Results:
We examined 2108 individuals aged 60 years and older, and found that 16.56% of them reported incidence headache. The results demonstrated a clear association between higher levels of frailty and higher risks of headaches. Higher FI was associated with 1% higher odds of having headaches (OR = 1.12, p < 0.001, 1 unit increase of FI). Individuals in highest quartile of FI had OR = 1.36 compared to the lowest quartiles of FI. Results of multi-variable logistic regression analysis consistently supported our findings in different adjusted models. Subgroup analyses showed similar results in different subgroups. Moreover, Mendelian Ran-domization analysis also supported the genetic correlation between frailty and headache phenotype (OR for FI and headache: 3.023 and 2.937, p < 0.001).
Conclusions:
The growing global burden of headaches, especially in older adults, underscores the urgency of targeted interventions. Our findings imply that frailty may be a potential indicator of headache risk, and they call for healthcare strategies to reduce the incidence of headache by intervening in frailty. In the future, we will focus on the biological processes underlying the frailty-headache association to provide credible targets for personalized treatment and evidence-based preventive care.
REFERENCES (56)
1.
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18: 459-80.
2.
Mielańczuk-Lubecka B, Głowacki K, Domitrz I. Neurologist and physiotherapist cooperation in the diagnostic process and treatment of cer-vicogenic headache. Arch Med Sci 2023; 19: 838-40.
3.
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and ter-ritories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789-858.
4.
Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7: 354-61.
5.
Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104.
6.
Huang G, Qian D, Liu Y, Qu G, Qian Y, Pei B. The association between frailty and osteoarthritis based on the NHANES and Mendelian ran-domization study. Arch Med Sci 2023; 19: 1545-50.
7.
Uchmanowicz I, Rosano G, Francesco Piepoli M, et al. The concurrent impact of mild cognitive impairment and frailty syndrome in heart failure. Arch Med Sci 2023; 19: 912-20.
8.
Zhou J, Li Y, Lin Y, et al. The genetic causal association between hip or knee osteoarthritis and frailty: a two-sample Mendelian randomiza-tion analysis. Arch Med Sci 2024; 20: 938-46.
9.
Steiner TJ, Birbeck GL, Jensen RH, Katsarava Z, Stovner LJ, Martelletti P. Headache disorders are third cause of disability worldwide. J Head-ache Pain 2015; 16: 58.
10.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive thera-py. Neurology 2007; 68: 343-9.
11.
Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 2012; 52: 1456-70.
12.
Ashina M. Migraine. N Engl J Med 2020; 383: 1866-76.
13.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory pro-cessing. Physiol Rev 2017; 97: 553-622.
14.
Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol 2018; 17: 174-82.
15.
Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: b3914.
16.
Rist PM, Winter AC, Buring JE, Sesso HD, Kurth T. Migraine and the risk of incident hypertension among women. Cephalalgia 2018; 38: 1817-24.
17.
Tsai CL, Chou CH, Lee PJ, et al. The potential impact of primary headache disorders on stroke risk. J Headache Pain 2016; 17: 108.
18.
Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012; 11: 92-100.
19.
Tiralongo G, Monte G, Ferilli MAN, et al. Pediatric-onset multiple sclerosis and primary headache: is there a link? Children (Basel) 2025; 12: 963.
20.
Morisaki Y, Maeda-Minami A, Sato M, et al. Association between frailty and use of potentially inappropriate medications in elderly hospi-talized patients: a cross-sectional study. In Vivo 2025; 39: 2986-92.
21.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381: 752-62.
22.
Mularski RA, Mittman B, Haupt E, et al. Performance of patient-reported outcome measures in a large pragmatic trial of home-based pallia-tive care (HomePal): methodological and practical considerations for embedded patient-centered design. J Palliat Med 2022; 25: 620-7.
23.
Dai Z, Wu Y, Chen J, Huang S, Zheng H. Assessment of relationships between frailty and chronic pain: a bidirectional two-sample Mendelian randomisation study. Age Ageing 2024; 53: afad256.
24.
Chen B, Wang M, He Q, et al. Impact of frailty, mild cognitive impairment and cognitive frailty on adverse health outcomes among commu-nity-dwelling older adults: a systematic review and meta-analysis. Front Med (Lausanne) 2022; 9: 1009794.
25.
Liu D, Ma Q, Zuo M, Niu Y, Wang J, Yan G. Association of 3-year change in frailty index with risk of all-cause mortality among older Chinese population: a national cohort study. BMC Geriatr 2024; 24: 1045.
26.
Uchmanowicz I. Investigating frailty and quality of life in patients with heart failure and CKD (FRAIL study). ESC Heart Fail 2025; 12: 5-7.
27.
Uchmanowicz B, Chudiak A, Uchmanowicz I, Mazur G. How may coexisting frailty influence adherence to treatment in elderly hypertensive patients? Int J Hypertens 2019; 2019: 5245184.
28.
Fujiki S, Minamisawa M, Nagata Y, et al. Baseline characteristics of patients with heart failure and mild cognitive impairment in cog-HF tri-al. J Cardiol 2025.
https://doi.org/10.1016/j.jjcc....
29.
Uchmanowicz I, Lee CS, Vitale C, et al. Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis. ESC Heart Fail 2020; 7: 3427-37.
30.
Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 2014; 43: 61-8.
31.
Abdulle AE, de Koning ME, van der Horn HJ, et al. Early predictors for long-term functional outcome after mild traumatic brain injury in frail elderly patients. J Head Trauma Rehabil 2018; 33: E59-67.
32.
Liu R, Chen L, Chen X. Causal relationship between Alzheimer’s disease and cerebral small vessel disease: a Mendelian randomization study. Transl Psychiatry 2025; 15: 317.
33.
Wei S, Quan Y, Li X, et al. Unveiling migraine subtype heterogeneity and risk loci: integrated genome-wide association study and single-cell transcriptomics discovery. J Headache Pain 2025; 26: 185.
34.
Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 2018; 362: k601.
35.
Fung C, Kraus LM, El Rahal A, et al. CSF Pressure and dynamics in patients with chronic postdural puncture headache: a single-center cohort study. Neurology 2025; 105: e213998.
36.
Vitale C, Uchmanowicz I. Frailty in patients with heart failure. Eur Heart J Suppl 2019; 21 (Suppl L): L12-6.
37.
Calila H, Bălășescu E, Nedelcu RI, Ion DA. Endothelial dysfunction as a key link between cardiovascular disease and frailty: a systematic review. J Clin Med 2024; 13: 2686.
38.
Egodage UK, Mohideen MS, Mohotti SP. Sex differences in migraine: bridging pathophysiology and clinical care in women. Adv Physiol Educ 2025; 49: 1109-15.
39.
Collerton J, Martin-Ruiz C, Davies K, et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 2012; 133: 456-66.
40.
Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015; 12: e1001779.
41.
Petschner P, Kumar S, Nguyen DA, et al. The interictal transcriptomic map of migraine without aura. J Headache Pain 2025; 26: 109.
42.
Wiemann M, Zimowski N, Blendow SL, et al. Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case-control study. J Neurol 2024; 271: 1850-60.
43.
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
44.
Brosch JR, Summanwar D, Fowler NR, et al. An innovative health systems approach to support early detection of cognitive impairment in primary care – the brain health navigator. BMC Prim Care 2025; 26: 271.
45.
Gale CR, Cooper C, Sayer AA. Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. Age Ageing 2015; 44: 162-5.
46.
Valdez-Gaxiola CA, Rosales-Leycegui F, Gaxiola-Rubio A, et al. DAOA and APOEε4 as modifiers of age of onset in autosomal-dominant early-onset Alzheimer’s disease caused by the PSEN1 A431E variant. Int J Mol Sci 2025; 26: 7929.
47.
Mahajan A. Limitations of cross-sectional studies. Neurol India 2015; 63: 1006-7.
48.
Wang Z, Dong YQ, Kumari S, Murphy D, Merchant RA. The impact of frailty, activity of daily living, and malnutrition on mortality in older adults with cognitive impairment and dementia. Nutrients 2025; 17: 2612.
49.
Islamoska S, Hansen ÅM, Wang HX, et al. Mid- to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J Headache Pain 2020; 21: 98.
50.
Lee SH, Shin DI, Lee SS. The insufficiency of a simple stress question in assessing stress for chronic daily headache in clinical practice. Clin Neurol Neurosurg 2023; 233: 107944.
51.
Morelli N, Barello S, Mayan M, Graffigna G. Supporting family caregiver engagement in the care of old persons living in hard to reach com-munities: a scoping review. Health Soc Care Community 2019; 27: 1363-74.
52.
Cocores AN, Smirnoff L, Greco G, Herrera R, Monteith TS. Update on neuromodulation for migraine and other primary headache disorders: recent advances and new indications. Curr Pain Headache Rep 2025; 29: 47.
53.
Padrós-Augé J, Espí-López GV, Pi-Martín M, Justribó-Manion C, Donat-Roca R. [Therapeutic exercise recommendations for primary head-aches treatment: a qualitative approach on the headache units in Catalonia]. Rev Esp Salud Publica 2025; 99: e202507041.
54.
Burch RC, Ailani J, Robbins MS. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache 2022; 62: 111-2.
55.
Steiner TJ, Buse DC, Al Jumah M, et al. The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide fol-low-up in primary care: development, psychometric evaluation and assessment of utility. J Headache Pain 2018; 19: 15.
56.
Mirzaeva LM, Lobzina AS, Akhmedova KN, et al. Therapeutic approaches to comorbid pathology in episodic migraine and tension-type headache. Zh Nevrol Psikhiatr Im S S Korsakova 2023; 123: 52-7.